Adverse events occurring after smallpox vaccination

Seminars in Pediatric Infectious Diseases

Volumn 14, Issue 3, 2003, Pages 189-195

  Lane, J Michael ^a   Goldstein, Joel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE; VACCINIA VACCINE;

CLINICAL FEATURE; ECZEMA; ERYTHEMA; FATALITY; HUMAN; POSTVACCINAL ENCEPHALITIS; REVACCINATION; REVIEW; SMALLPOX; URTICARIA; VACCINATION; VACCINATION REACTION; VACCINIA VIRUS; VIRUS STRAIN;

EID: 0042020232     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1045-1870(03)00032-3     Document Type: Article

References (56)

1. Lane JM, Ruben FL, Neff JM, et al: Complications of smallpox vaccination, 1968. National surveillance in the United States. N Engl J Med 281:1201-1208, 1969
2. Mack TM: Smallpox in Europe 1950-1971. J Infect Dis 125:161-169, 1972
3. Fenner F, Henderson DA, Arita I, et al: Smallpox and its eradication. Geneva, Switzerland, World Health Organization, 1988
4. Alibek K: Biohazard. New York, NY, Random House, 1999
5. Bicknell WJ: The case for voluntary smallpox vaccination. N Engl J Med 346:1323-1325, 2002
6. DeRugy V, Pena CV: Responding to the threat of smallpox bioterrorism. Policy Anal 434:1-16, 2002
7. Fauci AS: Smallpox vaccination policy: The need for dialogue. N Engl J Med 346:1319, 2002 (editorial)
8. Stevenson RW, Stolberg SG: Bush lays out plan on smallpox shots; military is first. NY Times December 14:A1, 2002
9. Connolly C: Bush inoculation plan near standstill. Medical professionals cite possible side effects, uncertainty of threat. The Washington Post February 24:A6, 2003
10. Wharton M, Strikas RA, Harpaz, R, et al: Recommendations for using smallpox vaccine in a pre-event smallpox vaccination program. Accessed May 19, 2003. URL: http:www.bt.cdc.gov/agent/smallpox/vaccination/acip-guidelines.asp
11. Frey SE, Couch RB, Tacket CO, et al: Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 346: 1265-1274, 2002
12. LeDuc JW, Damon I, Meegan JM, et al: Smallpox research activities: U.S. interagency collaboration, 2001. Emerg Infect Dis 8:743-745, 2002
13. Cono J, Casey CG, Bell DM: Smallpox vaccination and adverse reactions. Guidelines for clinicians. MMWR Recomm Rep 52: 1-28, 2003
14. Cooney EL, Collier AC, Greenberg PD, et al: Safety of and immunological response to a recombinant vaccinia virus expressing HIV envelope glycoprotein. Lancet 337:567-572, 1991
15. Blattner RJ, Norman JO, Heys FM, et al: Antibody response to cutaneous inoculation with vaccinia virus: Viremia and viruria in vaccinated children. J Pediatr 64:839-852, 1964
16. Kempe CH: Studies on smallpox and complications of smallpox vaccination. Pediatrics 26:176-189, 1960
17. Henderson DA, Moss B: Smallpox and vaccinia, in Plotkin S, Orenstein W (eds): Vaccines (ed 3). Philadelphia, Saunders, 1999, chap 6, pp 74-97
18. Moss B: Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci USA 93:11341-11348, 1996
19. Galasso GJ, Karzon DT, Katz SL, et al: Clinical and serological studies of four smallpox vaccines comparing variations of dose and route of administration. J Infect Dis 135:131-186, 1977
20. Kempe CH, Fulginiti V, Minamitani M, et al: Smallpox vaccination of eczema patients with a strain of live vaccinia (CV-178). Pediatrics 42:980-989, 1968
21. Enserink M: Bioterrorism. In search of a kinder gentler vaccine. Science 296:1594, 2002.
22. Stickl H, Hochstein-Mintzel V, Huber HC: Preliminary results with the highly attenuated vaccinia virus MVA. International Symposium of Smallpox Vaccine, Symposia Series in Immunobiological Standardization, vol 19. London, UK, S. Karger, 1973
23. Stittelaar KJ, Kuiken T, deSwart RL, et al: Safety of modified vaccinia Ankara (MVA) in immune-suppressed macaques. Vaccine 19:3700-3709, 2001
24. Tartaglia J, Perkus ME, Taylor J, et al: NYVAC: A highly attenuated strain of vaccinia virus. Virology 188:217-232, 1992
25. Cohen J: Looking for vaccines that pack a wallop without the side effects. Science 298:2314, 2002
26. Appleyard G, Hapel AJ, Boulter EA: An antigenic difference between intracellular and extracellular rabbitpox virus. J Gen Virol 13:9-17, 1971
27. Ada GL, Leung K-N, Ertl H: An analysis of effector T-cell generation and function in mice exposed to influenza A or Sendai viruses. Immunol Rev 58:5-24, 1981
28. Rosenthal SR, Merchlinsky M, Kleppinger C, et al: Developing new smallpox vaccines. Emerg Infect Dis 7:920-926, 2001
29. Fulginiti VA, Eller JJ, Downie AW, et al: Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 202:1075-1080, 1967
30. De Vries E: Postvaccinial Perivenous Encephalitis. Amsterdam Elsevier, 1959
31. Fulginiti VA, Kempe CH, Hathaway WE, et al: Progressive vaccinia in immunologically deficient individuals. New York: The National Foundation-March of Dimes, Birth Defects, Original Article Series, Immunologic Deficiency Diseases in Man 4:129-45, 1968
32. Lane JM, Ruben FL, Abrutyn E, et al: Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968. JAMA 212:441-444, 1970
33. Copeman PMW, Wallace HJL: Eczema vaccinatum. BMJ 2:906-908, 1964
34. Raimer SS: Managing pediatric atopic dermatitis. Clin Pediatr 39:1-14, 2000
35. Laughter D, Istvan JA, Tofte SA, et al: The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 43:649-655, 2000
36. Engler RJ, Kenner J, Leung DY: Smallpox vaccination: Risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 110:357-365, 2002
37. Ruben FL, Lane JM: Ocular vaccinia. Arch Ophthal 84:45-48, 1970
38. Fulginiti VA, Winograd LA, Jackson M, et al: Therapy of experimental vaccinal keratitis. Arch Ophthal 74:539-544, 1965
39. Neff JM, Drachman RA: Complications of smallpox vaccination, 1968. Surveillance in a comprehensive care clinic. Pediatrics 50:481-482, 1972
40. CDC: Women with smallpox vaccine exposure during pregnancy reported to the national smallpox vaccine in pregnancy registry - United States, 2003, MMWR 52:386-388, 2003
41. Karjalainen J, Heikkila J, Nieminen MS, et al: Etiology of mild acute infectious myocarditis. Acta Med Scand 213:65-73, 1983
42. Helle EJ, Koskenvuo K, Heikkila J, et al: Myocardial complications of immunizations. Ann Clin Res 10:280-287, 1978
43. Finlay-Jones LR: Fatal myocarditis after vaccination against smallpox: Report of a case. N Engl J Med 270:41-42, 1964
44. Ferry BJ: Adverse reactions after smallpox vaccination. Med J Australia 2:180-183, 1977
45. Dalgaard JB: Fatal myocarditis following smallpox vaccination. Am Heart J 54:156-157, 1957
46. Neff JM, Lane JM, Fulginiti VA, et al: Contact vaccinia-transmission of vaccinia from smallpox vaccination. JAMA 288:1901-1905, 2002
47. Sepkowitz KA: Current concepts: How contagious is vaccinia? N Engl J Med 348:439-446, 2003
48. Gurvich EB, Braginskaya VP, Shenkman LS, et al: Isolation of vaccinia virus from the pharynx of children vaccinated against smallpox. J Hyg Epid Micro and Immunol 18:69-79, 1974
49. Kesson AM, Ferguson JK, Rawlinson WD, et al: Progressive vaccinia treated with ribavirin and vaccinia immune globulin. Clin Infect Dis 25:911-914, 1997
50. Bradbury J: Orally available cidofovir derivative active against smallpox. Lancet 359:1041, 2002
51. Demkowicz WE Jr, Littaua RA, Wang J, et al: Human cytotoxic T-cell memory: Long lived response to vaccinia virus. J Virol 70:2627-2631, 1996
52. Cohen J: Smallpox vaccinations: How much protection remains? Science 294:985, 2001
53. El-Al B, Roth Y, Winder A, et al: The persistence of neutralizing antibodies after revaccination against smallpox. J Infect Dis 161:446-448, 1990
54. Lane JM, Ruben FL, Neff JM, et al: Complications of smallpox vaccination, 1968: Results of ten statewide surveys. J Infect Dis 122:303-309, 1970.
55. Grabenstein JD, Winkenwerder W: US military smallpox vaccination program experience. JAMA 289:3278-3282, 2003
56. Halsell JS, Riddle JR, Atwood JE, et al: Myopericarditis following smallpox vaccination among vaccinia-naïve US military personnel. JAMA 239:3283-3306, 2003